A citation-based method for searching scientific literature

Charlie C Park, Phirum Nguyen, Carolyn Hernandez, Ricki Bettencourt, Kimberly Ramirez, Lynda Fortney, Jonathan Hooker, Ethan Sy, Michael T Savides, Mosab H Alquiraish, Mark A Valasek, Emily Rizo, Lisa Richards, David Brenner, Claude B Sirlin, Rohit Loomba. Gastroenterology 2017
Times Cited: 349







List of co-cited articles
1322 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.
Kento Imajo, Takaomi Kessoku, Yasushi Honda, Wataru Tomeno, Yuji Ogawa, Hironori Mawatari, Koji Fujita, Masato Yoneda, Masataka Taguri, Hideyuki Hyogo,[...]. Gastroenterology 2016
440
44

Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
David E Kleiner, Elizabeth M Brunt, Mark Van Natta, Cynthia Behling, Melissa J Contos, Oscar W Cummings, Linda D Ferrell, Yao-Chang Liu, Michael S Torbenson, Aynur Unalp-Arida,[...]. Hepatology 2005
37

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
Naga Chalasani, Zobair Younossi, Joel E Lavine, Michael Charlton, Kenneth Cusi, Mary Rinella, Stephen A Harrison, Elizabeth M Brunt, Arun J Sanyal. Hepatology 2018
37

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Zobair M Younossi, Aaron B Koenig, Dinan Abdelatif, Yousef Fazel, Linda Henry, Mark Wymer. Hepatology 2016
36

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
Parambir S Dulai, Siddharth Singh, Janki Patel, Meera Soni, Larry J Prokop, Zobair Younossi, Giada Sebastiani, Mattias Ekstedt, Hannes Hagstrom, Patrik Nasr,[...]. Hepatology 2017
876
26

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Peter J Eddowes, Magali Sasso, Michael Allison, Emmanouil Tsochatzis, Quentin M Anstee, David Sheridan, Indra N Guha, Jeremy F Cobbold, Jonathan J Deeks, Valérie Paradis,[...]. Gastroenterology 2019
424
25

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
Laurent Castera, Mireen Friedrich-Rust, Rohit Loomba. Gastroenterology 2019
534
24

The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD.
Paul Angulo, Jason M Hui, Giulio Marchesini, Ellisabetta Bugianesi, Jacob George, Geoffrey C Farrell, Felicity Enders, Sushma Saksena, Alastair D Burt, John P Bida,[...]. Hepatology 2007
24

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.
Paul Angulo, David E Kleiner, Sanne Dam-Larsen, Leon A Adams, Einar S Bjornsson, Phunchai Charatcharoenwitthaya, Peter R Mills, Jill C Keach, Heather D Lafferty, Alisha Stahler,[...]. Gastroenterology 2015
23

Sampling variability of liver biopsy in nonalcoholic fatty liver disease.
Vlad Ratziu, Frédéric Charlotte, Agnès Heurtier, Sophie Gombert, Philippe Giral, Eric Bruckert, André Grimaldi, Frédérique Capron, Thierry Poynard. Gastroenterology 2005
22


Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants.
Cynthia Hsu, Cyrielle Caussy, Kento Imajo, Jun Chen, Siddharth Singh, Kellee Kaulback, Minh-Da Le, Jonathan Hooker, Xin Tu, Ricki Bettencourt,[...]. Clin Gastroenterol Hepatol 2019
156
22

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
Richard K Sterling, Eduardo Lissen, Nathan Clumeck, Ricard Sola, Mendes Cassia Correa, Julio Montaner, Mark S Sulkowski, Francesca J Torriani, Doug T Dieterich, David L Thomas,[...]. Hepatology 2006
21


Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.
Thomas Karlas, David Petroff, Magali Sasso, Jian-Gao Fan, Yu-Qiang Mi, Victor de Lédinghen, Manoj Kumar, Monica Lupsor-Platon, Kwang-Hyub Han, Ana C Cardoso,[...]. J Hepatol 2017
463
19

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stål, Stergios Kechagias, Rolf Hultcrantz. Hepatology 2015
19

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
Philip N Newsome, Magali Sasso, Jonathan J Deeks, Angelo Paredes, Jérôme Boursier, Wah-Kheong Chan, Yusuf Yilmaz, Sébastien Czernichow, Ming-Hua Zheng, Vincent Wai-Sun Wong,[...]. Lancet Gastroenterol Hepatol 2020
202
19

Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis.
Cyrielle Caussy, Mosab H Alquiraish, Phirum Nguyen, Carolyn Hernandez, Sandra Cepin, Lynda E Fortney, Veeral Ajmera, Ricki Bettencourt, Summer Collier, Jonathan Hooker,[...]. Hepatology 2018
164
18

Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial).
Rohit Loomba, Claude B Sirlin, Brandon Ang, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Linda Soaft, Jonathan Hooker, Yuko Kono, Archana Bhatt,[...]. Hepatology 2015
243
17

Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
Saumya Jayakumar, Michael S Middleton, Eric J Lawitz, Parvez S Mantry, Stephen H Caldwell, Hays Arnold, Anna Mae Diehl, Reem Ghalib, Magdy Elkhashab, Manal F Abdelmalek,[...]. J Hepatol 2019
110
16

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.
Zobair Younossi, Quentin M Anstee, Milena Marietti, Timothy Hardy, Linda Henry, Mohammed Eslam, Jacob George, Elisabetta Bugianesi. Nat Rev Gastroenterol Hepatol 2018
16

Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease.
An Tang, Ajinkya Desai, Gavin Hamilton, Tanya Wolfson, Anthony Gamst, Jessica Lam, Lisa Clark, Jonathan Hooker, Tanya Chavez, Brandon D Ang,[...]. Radiology 2015
158
15

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis.
Ruben Hernaez, Mariana Lazo, Susanne Bonekamp, Ihab Kamel, Frederick L Brancati, Eliseo Guallar, Jeanne M Clark. Hepatology 2011
823
14

Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials.
Mazen Noureddin, Jessica Lam, Michael R Peterson, Michael Middleton, Gavin Hamilton, Thuy-Anh Le, Ricki Bettencourt, Chris Changchien, David A Brenner, Claude Sirlin,[...]. Hepatology 2013
325
14

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.
Rohit Loomba, Tanya Wolfson, Brandon Ang, Jonathan Hooker, Cynthia Behling, Michael Peterson, Mark Valasek, Grace Lin, David Brenner, Anthony Gamst,[...]. Hepatology 2014
299
14

Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials.
Cyrielle Caussy, Scott B Reeder, Claude B Sirlin, Rohit Loomba. Hepatology 2018
173
14

Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.
An Tang, Justin Tan, Mark Sun, Gavin Hamilton, Mark Bydder, Tanya Wolfson, Anthony C Gamst, Michael Middleton, Elizabeth M Brunt, Rohit Loomba,[...]. Radiology 2013
311
13

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
Siddharth Singh, Alina M Allen, Zhen Wang, Larry J Prokop, Mohammad H Murad, Rohit Loomba. Clin Gastroenterol Hepatol 2015
837
13

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis.
Zobair M Younossi, Pegah Golabi, Leyla de Avila, James Minhui Paik, Manirath Srishord, Natsu Fukui, Ying Qiu, Leah Burns, Arian Afendy, Fatema Nader. J Hepatol 2019
647
13

MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis.
Jinho Jung, Rohan R Loomba, Kento Imajo, Egbert Madamba, Sanil Gandhi, Ricki Bettencourt, Seema Singh, Carolyn Hernandez, Mark A Valasek, Cynthia Behling,[...]. Gut 2021
30
43

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.
Jérôme Boursier, Julien Vergniol, Anne Guillet, Jean-Baptiste Hiriart, Adrien Lannes, Brigitte Le Bail, Sophie Michalak, Faiza Chermak, Sandrine Bertrais, Juliette Foucher,[...]. J Hepatol 2016
208
13

Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.
Mohammad S Siddiqui, Raj Vuppalanchi, Mark L Van Natta, Erin Hallinan, Kris V Kowdley, Manal Abdelmalek, Brent A Neuschwander-Tetri, Rohit Loomba, Srinivasan Dasarathy, Danielle Brandman,[...]. Clin Gastroenterol Hepatol 2019
171
12


Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity.
Jun Chen, Meng Yin, Jayant A Talwalkar, Jennifer Oudry, Kevin J Glaser, Thomas C Smyrk, Véronique Miette, Laurent Sandrin, Richard L Ehman. Radiology 2017
97
12

Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis.
Stuart McPherson, Tim Hardy, Jean-Francois Dufour, Salvatore Petta, Manuel Romero-Gomez, Mike Allison, Claudia P Oliveira, Sven Francque, Luc Van Gaal, Jörn M Schattenberg,[...]. Am J Gastroenterol 2017
322
12

Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis.
Siddharth Singh, Sudhakar K Venkatesh, Rohit Loomba, Zhen Wang, Claude Sirlin, Jun Chen, Meng Yin, Frank H Miller, Russell N Low, Tarek Hassanein,[...]. Eur Radiol 2016
140
12

Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Rod S Taylor, Rebecca J Taylor, Sue Bayliss, Hannes Hagström, Patrik Nasr, Jorn M Schattenberg, Masatoshi Ishigami, Hidenori Toyoda, Vincent Wai-Sun Wong, Noam Peleg,[...]. Gastroenterology 2020
315
12

Magnetic resonance elastography of liver: technique, analysis, and clinical applications.
Sudhakar K Venkatesh, Meng Yin, Richard L Ehman. J Magn Reson Imaging 2013
398
11

The global NAFLD epidemic.
Rohit Loomba, Arun J Sanyal. Nat Rev Gastroenterol Hepatol 2013
11


Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease.
Amy G Shah, Alison Lydecker, Karen Murray, Brent N Tetri, Melissa J Contos, Arun J Sanyal. Clin Gastroenterol Hepatol 2009
780
11

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.
Mohammed Eslam, Philip N Newsome, Shiv K Sarin, Quentin M Anstee, Giovanni Targher, Manuel Romero-Gomez, Shira Zelber-Sagi, Vincent Wai-Sun Wong, Jean-François Dufour, Jörn M Schattenberg,[...]. J Hepatol 2020
11

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials.
Beth A Davison, Stephen A Harrison, Gad Cotter, Naim Alkhouri, Arun Sanyal, Christopher Edwards, Jerry R Colca, Julie Iwashita, Gary G Koch, Howard C Dittrich. J Hepatol 2020
114
11

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.
Magali Sasso, Michel Beaugrand, Victor de Ledinghen, Catherine Douvin, Patrick Marcellin, Raoul Poupon, Laurent Sandrin, Véronique Miette. Ultrasound Med Biol 2010
487
10

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.
Hannes Hagström, Patrik Nasr, Mattias Ekstedt, Ulf Hammar, Per Stål, Rolf Hultcrantz, Stergios Kechagias. J Hepatol 2017
467
10

ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis.
Samuel J Daniels, Diana J Leeming, Mohammed Eslam, Ahmed M Hashem, Mette J Nielsen, Aleksander Krag, Morten A Karsdal, Jane I Grove, Indra Neil Guha, Takumi Kawaguchi,[...]. Hepatology 2019
109
10

Prospective, Same-Day, Direct Comparison of Controlled Attenuation Parameter With the M vs the XL Probe in Patients With Nonalcoholic Fatty Liver Disease, Using Magnetic Resonance Imaging-Proton Density Fat Fraction as the Standard.
Cyrielle Caussy, Justine Brissot, Seema Singh, Shirin Bassirian, Carolyn Hernandez, Ricki Bettencourt, Emily Rizo, Lisa Richards, Claude B Sirlin, Rohit Loomba. Clin Gastroenterol Hepatol 2020
27
37

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population.
Giorgio Bedogni, Stefano Bellentani, Lucia Miglioli, Flora Masutti, Marilena Passalacqua, Anna Castiglione, Claudio Tiribelli. BMC Gastroenterol 2006
10

Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis.
David Petroff, Valentin Blank, Philip N Newsome, Shalimar, Cosmin Sebastian Voican, Maja Thiele, Victor de Lédinghen, Stephan Baumeler, Wah Kheong Chan, Gabriel Perlemuter,[...]. Lancet Gastroenterol Hepatol 2021
62
16

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.
Jun Chen, Jayant A Talwalkar, Meng Yin, Kevin J Glaser, Schuyler O Sanderson, Richard L Ehman. Radiology 2011
304
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.